Biopharma | May 07, 2026
China poised to launch world’s first CAR-T therapy for gastric cancer
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The drug is also intended for the treatment of glioblastoma multiforme
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
